HealthCapital Berlin Brandenburg

digitalHealthCapital@DMEA2026

20 – 24 Apr 2026 | Berlin, Germany

MyImmune Corporation

Startup

www.myimmune.ai/Wilmington, United States
9 profile visits

About

MyImmune (also known as MyImmune Corporation) is a precision medicine biotechnology company focused on decoding the human immune system to transform disease diagnosis and treatment. Founded in 2024 and leveraging research from Osaka University, the company utilizes an advanced artificial intelligence platform to analyze adaptive immune receptor data (such as B-cell and T-cell receptors). Their technology aims to predict patient responses to immunotherapies and diagnose conditions like cancer, autoimmune disorders, and neurodegenerative diseases rapidly through a single blood test, ultimately enabling more personalized and effective therapeutic strategies.

Medical field

DiagnosticsWomen's Health

Data and analytics

Data science and analyticsMachine learning / Artificial intelligence

Software and mobile applications

Others (software)

Representatives

Co-founder & CEO MyImmune

MyImmune Corporation